CRINETICS PHARMACEUTICALS INC. - COMMON STOCK
53.14
04-十月-24 15:59:59
15 分钟延时
股票
+0.37
+0.70%
今日范围
52.73 - 53.59
ISIN
N/A
来源
NASDAQ
-
Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly
26 9月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
10 9月 2024 16:40:25 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences
29 8月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
12 8月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
08 8月 2024 16:05:01 条件 Nasdaq GlobeNewswire
-
08 8月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024
18 7月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 7月 2024 19:29:44 条件 Nasdaq GlobeNewswire
-
18 6月 2024 16:30:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 6月 2024 18:35:30 条件 Nasdaq GlobeNewswire
-
03 6月 2024 12:00:00 条件 Nasdaq GlobeNewswire
-
30 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Early Release of ENDO 2024 Late-Breaking Abstracts
22 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 5月 2024 17:38:21 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
09 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
08 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
02 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
11 4月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
19 3月 2024 06:00:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >